In the past few years, privacy concerns have grown, making the financial models of businesses more vulnerable to attack. In many cases, it is hard to emphasize the importance of monitoring things in real-time with data from Internet of Things (IoT) devices. The people who make the IoT devices and those who use them face big problems when they try to use Artificial Intelligence (AI) techniques in real-world applications, where data must be collected and processed at a central location. Federated learning (FL) has made a decentralized, cooperative AI system that can be used by many IoT apps that use AI. It is possible because it can train AI on IoT devices that are spread out and do not need to share data. FL allows local models to be trained on local data and share their knowledge to improve a global model. Also, shared learning allows models from all over the world to be trained using data from all over the world. This article looks at the IoT in all of its forms, including "smart" businesses, "smart" cities, "smart" transportation, and "smart" healthcare. This study looks at the safety problems that the federated learning with IoT (FL-IoT) area has brought to market. This research is needed to explore because federated learning is a new technique, and a small amount of work is done on challenges faced during integration with IoT. This research also helps in the real world in such applications where encrypted data must be sent from one place to another. Researchers and graduate students are the audience of our article.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10773731 | PMC |
http://dx.doi.org/10.7717/peerj-cs.1657 | DOI Listing |
PLoS One
December 2024
Medical Physics, Department of Diagnostic and Interventional Radiology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Background And Purpose: External drainage represents a well-established treatment option for acute intracerebral hemorrhage. The current standard of practice includes post-operative computer tomography imaging, which is subjectively evaluated. The implementation of an objective, automated evaluation of postoperative studies may enhance diagnostic accuracy and facilitate the scaling of research projects.
View Article and Find Full Text PDFPLOS Digit Health
December 2024
School of Public Health, University of São Paulo, São Paulo, Brazil.
Machine learning (ML) is a promising tool in assisting clinical decision-making for improving diagnosis and prognosis, especially in developing regions. It is often used with large samples, aggregating data from different regions and hospitals. However, it is unclear how this affects predictions in local centers.
View Article and Find Full Text PDFAbdom Radiol (NY)
December 2024
Brazilian Center for Evidence-Based Research, Federal University of Santa Catarina, Florianópolis, Brazil.
Purpose: To evaluate the diagnostic ability and methodological quality of ML models in detecting Pancreatic Ductal Adenocarcinoma (PDAC) in Contrast CT images.
Method: Included studies assessed adults diagnosed with PDAC, confirmed by histopathology. Metrics of tests were interpreted by ML algorithms.
RMD Open
December 2024
Department of Gastroenterology, Infectious Diseases and Rheumatology (incl. Nutrition Medicine), Charite - Universitatsmedizin Berlin, Berlin, Germany.
Purpose: To examine whether incorporating anatomy-centred deep learning can improve generalisability and enable prediction of disease progression.
Methods: This retrospective multicentre study included conventional pelvic radiographs of four different patient cohorts focusing on axial spondyloarthritis collected at university and community hospitals. The first cohort, which consisted of 1483 radiographs, was split into training (n=1261) and validation (n=222) sets.
Biomed Khim
December 2024
Chemoinformatics Group - NEQUIM, Departamento de Quimica, Instituto de Ciências Exatas, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.
Traditional testing methods in pharmaceutical development can be time-consuming and costly, but in silico evaluation tools can offer a solution. Our in-house Active-IT system, a Ligand-Based Virtual Screening (LBVS) tool, was developed to predict the biological and pharmacological activities of small organic molecules. It includes four independent modules for generating molecular descriptors (3D-Pharma), machine learning modeling (ExCVBA), a database of bioactivity models, and a prediction module.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!